Solid Biosciences Inc. (SLDB) Cash Flow Statement
Solid Biosciences Inc. (SLDB) generated -$186.8M of operating cash flow over the twelve months to 2026-06-30, spent $965000 on capital expenditure and had free cash flow of -$187.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SLDBSolid Biosciences Inc.Follow SLDB — free
—
Price chart with a free account
- Market cap
- 634.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -70.2 | -92.7 | -56.6 | -77.8 | -98.0 | -94.2 | -100.0 | -156.3 | -186.8 | |
| Capital expenditure | 7.8 | 4.4 | 0.9 | 1.3 | 3.0 | 1.5 | 0.7 | 1.2 | -1.0 | |
| Free cash flow | -78.0 | -97.1 | -57.5 | -79.0 | -101.0 | -95.7 | -100.7 | -157.4 | -187.8 | |
| Stock-based compensation | 6.0 | 14.2 | 11.6 | 13.4 | 7.5 | 7.6 | 10.5 | 16.9 | — |
USD millions · SEC XBRL
Solid Biosciences Inc. — questions
- What is Solid Biosciences Inc.'s operating cash flow?
- -$186.8M over the twelve months to 2026-06-30.
- How much does Solid Biosciences Inc. spend on capital expenditure?
- $965000 over the twelve months to 2026-06-30.
- What is Solid Biosciences Inc.'s free cash flow?
- -$187.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Solid Biosciences Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.